223 related articles for article (PubMed ID: 33988300)
1. Leptin receptor is a key gene involved in the immunopathogenesis of thyroid-associated ophthalmopathy.
Chen Z; Chen Z; Wang J; Zhang M; Wang X; Cuomu D; Shi B; Wang Y
J Cell Mol Med; 2021 Jun; 25(12):5799-5810. PubMed ID: 33988300
[TBL] [Abstract][Full Text] [Related]
2. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between thyroid-associated orbitopathy and Graves' disease by iTRAQ-based quantitative proteomic analysis.
Kang J; Li Y; Zhao Z; Zhang H
FEBS Open Bio; 2021 Jul; 11(7):1930-1940. PubMed ID: 33934566
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy.
Wang Y; Shao Y; Zhang H; Wang J; Zhang P; Zhang W; Chen H
BMC Genomics; 2022 Sep; 23(1):630. PubMed ID: 36056316
[TBL] [Abstract][Full Text] [Related]
5. Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated Ophthalmopathy.
Fernando R; Smith TJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):e20-e33. PubMed ID: 32968816
[TBL] [Abstract][Full Text] [Related]
6. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
[TBL] [Abstract][Full Text] [Related]
7. Differentially expressed genes in orbital adipose/connective tissue of thyroid-associated orbitopathy.
Wang Y; Liu Y; Cai J; Zong T; Zhang Z; Xie T; Mu T; Wu M; Yang Q; Wang Y; Wang X; Yao Y
PeerJ; 2023; 11():e16569. PubMed ID: 38130930
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment of Graves' disease and main extrathyroidal manifestation, Graves' ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue.
Ji DY; Park SH; Park SJ; Kim KH; Ku CR; Shin DY; Yoon JS; Lee DY; Lee EJ
Sci Rep; 2018 Jun; 8(1):9262. PubMed ID: 29915201
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of thyroid associated ophthalmopathy after arterial embolization therapy in a patient with Graves' disease.
Hiraiwa T; Imagawa A; Yamamoto K; Arimoto H; Arishima T; Ito M; Nakamura Y; Matsuzuka F; Miyauchi A; Sugasawa J; Ikeda T; Narumi Y; Hanafusa T
Endocrine; 2009 Jun; 35(3):302-5. PubMed ID: 19381887
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.
Wang Y; Smith TJ
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1735-48. PubMed ID: 24651704
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 Inhibits T Cell-Induced Cytokines and Hyaluronan Expression
Liu Z; Liu Y; Liu M; Gong Q; Shi A; Li X; Bai X; Guan X; Hao B; Liu F; Zhou X; Yuan H
Front Immunol; 2022; 13():849480. PubMed ID: 35619700
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 enhances the expression of functional TSH receptor in orbital fibroblasts from thyroid-associated ophthalmopathy.
Paik JS; Kim SE; Kim JH; Lee JY; Yang SW; Lee SB
Immunobiology; 2020 Mar; 225(2):151902. PubMed ID: 31899052
[TBL] [Abstract][Full Text] [Related]
15. Machine learning-based prediction of diagnostic markers for Graves' orbitopathy.
Cai Y; Su H; Si Y; Ni N
Endocrine; 2023 Aug; 81(2):277-289. PubMed ID: 37059863
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease.
Lim SL; Lim AK; Mumtaz M; Hussein E; Wan Bebakar WM; Khir AS
Thyroid; 2008 Dec; 18(12):1297-301. PubMed ID: 19012471
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
[TBL] [Abstract][Full Text] [Related]
18. Differentially expressed circular RNAs in orbital adipose/connective tissue from patients with thyroid-associated ophthalmopathy.
Wu L; Zhou R; Diao J; Chen X; Huang J; Xu K; Ling L; Xia W; Liang Y; Liu G; Sun X; Qin B; Zhao C
Exp Eye Res; 2020 Jul; 196():108036. PubMed ID: 32376473
[TBL] [Abstract][Full Text] [Related]
19. IGF1 receptor and thyroid-associated ophthalmopathy.
Mohyi M; Smith TJ
J Mol Endocrinol; 2018 Jul; 61(1):T29-T43. PubMed ID: 29273685
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
